Antibody-Based Immunotherapeutic Strategies for COVID-19

Global efforts to contain the coronavirus disease-2019 (COVID-19) include the development of novel preventive vaccines and effective therapeutics. Passive antibody therapies using convalescent plasma, SARS-CoV-2 (Severe-Acute-Respiratory-Syndrome-Corona-Virus-2)-specific neutralizing antibodies (NAb...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussen, Jamal, Kandeel, Mahmoud, Hemida, Maged Gomaa, Al-Mubarak, Abdullah I. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694378/
https://www.ncbi.nlm.nih.gov/pubmed/33167401
http://dx.doi.org/10.3390/pathogens9110917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694378/
https://www.ncbi.nlm.nih.gov/pubmed/33167401
http://dx.doi.org/10.3390/pathogens9110917

Ejemplares similares